home.social

#digitalpathology — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #digitalpathology, aggregated by home.social.

  1. 🥳 Great to meet at #ECDP2026 some of the OC of our #Compayl day at this year’s #MICCAI.

    📣 Submit and join this full day on #PathologyAI for a tutorial, workshop and the #Reg2026 challenge!

    ℹ️ at compayl.com

    #ESDIP #ASDP #ComputationalPathology #DigitalPathology #AI #MedicalAI

  2. It’s been a fantastic meeting with friends at #ECDP2026 in #Graz, Austria. Cutting edge science, great discussions, and many fun events! Can’t wait for next year’s in Rotterdam.

    #ESDIP #PathologyAI #ComputationalPathology #DigitalPathology #AI #MedicalAI

  3. Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics

    The Danaher company expands its collaboration with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2…
    #EuropeSays #Britain #Europe #EU #AstraZeneca #analysisalgorithm #assaydevelopment #cancerdiagnostics #Collaboration #DaiichiSankyo #digitalpathology #LeicaBiosystems
    europesays.com/britain/55275/

  4. Pathology Slide QC AI Market Set to Reach $1.37B by 2030 🚀

    The pathology slide quality control AI market is growing fast—rising from $0.53B in 2025 to $1.38B by 2030 at a 21% CAGR. Growth is driven by digital pathology adoption, higher diagnostic volumes, workflow automation, and AI-based quality assurance.

    🔗 Free sample:
    thebusinessresearchcompany.com

    #AI #DigitalPathology #HealthcareAI #MarketResearch

  5. The Single Arm Survival tool in jamovi #jsurvival module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.
    #Pathology #DigitalPathology #Biostatistics #Oncology #SurvivalAnalysis #jamovi

  6. The Single Arm Survival tool in jamovi #jsurvival module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.
    #Pathology #DigitalPathology #Biostatistics #Oncology #SurvivalAnalysis #jamovi

  7. The Single Arm Survival tool in jamovi #jsurvival module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.
    #Pathology #DigitalPathology #Biostatistics #Oncology #SurvivalAnalysis #jamovi

  8. The Single Arm Survival tool in jamovi #jsurvival module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.
    #Pathology #DigitalPathology #Biostatistics #Oncology #SurvivalAnalysis #jamovi

  9. The Single Arm Survival tool in jamovi #jsurvival module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.
    #Pathology #DigitalPathology #Biostatistics #Oncology #SurvivalAnalysis #jamovi

  10. The Single Arm Survival tool in jamovi module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.

  11. The Single Arm Survival tool in jamovi #jsurvival module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.
    #Pathology #DigitalPathology #Biostatistics #Oncology #SurvivalAnalysis #jamovi

  12. The Single Arm Survival tool in jamovi #jsurvival module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.
    #Pathology #DigitalPathology #Biostatistics #Oncology #SurvivalAnalysis #jamovi

  13. The Single Arm Survival tool in jamovi #jsurvival module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.
    #Pathology #DigitalPathology #Biostatistics #Oncology #SurvivalAnalysis #jamovi

  14. The Single Arm Survival tool in jamovi #jsurvival module singlearm function
    analyzes overall survival characteristics for phase II trials, cancer registries, and cohort studies. Simply input time-to-event data (or diagnosis/follow-up dates) and outcome status.
    #Pathology #DigitalPathology #Biostatistics #Oncology #SurvivalAnalysis #jamovi

  15. AI Vision in Pathology: In the near future, pathology labs will look very different from the traditional model of glass slides and a single expert at a microscope.
    know more:zurl.co/9HRFD
    #AIVision #DigitalPathology #HealthcareAI #MedicalImaging #Diagnostics

  16. The FDA has qualified AIM-NASH, the first AI histology tool used as a drug-development endpoint, to read liver biopsies in MASH trials. What happens when an algorithm helps decide if a drug works?
    biotech.industryexaminer.com/f
    #biotech #AIinBiotech #liverdisease #MASH #digitalpathology #clinicaltrials #regulatoryscience #TechNews

  17. The FDA has qualified AIM-NASH, the first AI histology tool used as a drug-development endpoint, to read liver biopsies in MASH trials. What happens when an algorithm helps decide if a drug works?
    biotech.industryexaminer.com/f
    #biotech #AIinBiotech #liverdisease #MASH #digitalpathology #clinicaltrials #regulatoryscience #TechNews

  18. The FDA has qualified AIM-NASH, the first AI histology tool used as a drug-development endpoint, to read liver biopsies in MASH trials. What happens when an algorithm helps decide if a drug works?
    biotech.industryexaminer.com/f
    #biotech #AIinBiotech #liverdisease #MASH #digitalpathology #clinicaltrials #regulatoryscience #TechNews

  19. The FDA has qualified AIM-NASH, the first AI histology tool used as a drug-development endpoint, to read liver biopsies in MASH trials. What happens when an algorithm helps decide if a drug works?
    biotech.industryexaminer.com/f
    #biotech #AIinBiotech #liverdisease #MASH #digitalpathology #clinicaltrials #regulatoryscience #TechNews

  20. 🔬 Digital pathology is no longer the future—it’s transforming diagnostics today.
    AI, molecular biology, and cloud platforms are reshaping how pathologists work. From 99% diagnostic accuracy to faster workflows and real‑time global collaboration, digital pathology is changing patient care and precision medicine.

    Read more 👉 blog.banishcancer.org/digital-

    #DigitalPathology #Oncology #AIinHealthcare #PrecisionMedicine #CancerDiagnostics #BanishCancer

  21. 🔬 Digital pathology is no longer the future—it’s transforming diagnostics today.
    AI, molecular biology, and cloud platforms are reshaping how pathologists work. From 99% diagnostic accuracy to faster workflows and real‑time global collaboration, digital pathology is changing patient care and precision medicine.

    Read more 👉 blog.banishcancer.org/digital-

    #DigitalPathology #Oncology #AIinHealthcare #PrecisionMedicine #CancerDiagnostics #BanishCancer

  22. 🔬 Digital pathology is no longer the future—it’s transforming diagnostics today.
    AI, molecular biology, and cloud platforms are reshaping how pathologists work. From 99% diagnostic accuracy to faster workflows and real‑time global collaboration, digital pathology is changing patient care and precision medicine.

    Read more 👉 blog.banishcancer.org/digital-

    #DigitalPathology #Oncology #AIinHealthcare #PrecisionMedicine #CancerDiagnostics #BanishCancer